In the year 2022, approximately 109 SME firms went public, collectively raising around Rs 1,875 crore through IPOs. By comparison, in 2021, 59 SME firms were listed, raising a total of Rs 746 crore.
Brokerage firm Macquarie Research has given Mankind Pharma Ltd an outperform rating with a target price of Rs 1400 per share, indicating a potential upside of 29.6% from its issue price of Rs 1068 per share.
Adani Wilmar is the top-performing IPO trading around 174 percent higher than its issue price, while ASG Transact posted a 57 percent decline in stock price. Among other notables, Life Insurance Corporation and Delhivery stocks are down 34 percent each.
The anchor investors bidding will start on 9 December. The firm will start crediting shares on 21 December and the stock will be listed on exchanges on 22 December.
Archean Chemicals Industries Ltd, Five Star Business Finance Ltd, Kaynes Technology India and Inox Green Energy Services will be out next week. More IPOs are lined up for mid-November
Its shares have dropped 35% in the grey market from their peak of Rs 730 a share in October 2021. Five Star Business is not the only one to set the IPO band lower than the unlisted market price.
The south-based lender has cut its IPO size to Rs 1,960 crore from Rs 2,752 crore earlier planned. The issue will be a pure offer for sale
Bengaluru-based DCX Systems Ltd, cardiologist Dr Naresh Trehan-promoted Global Health Ltd, Bikaji Foods International Ltd and Fusion Micro Finance Ltd are looking to raise funds in the primary market
The IPO, which will close on November 4, consists of a fresh issue of Rs 600 crore and an offer for sale of up to 13.70 million shares
The IPO, which will close on November 7, consists of a fresh issue of Rs 500 crore and an offer for sale of up to 50.76 million shares by shareholders and promoters
The IPO consists of a fresh issue of shares worth Rs 625 crore and an offer for sale of up to 17 million shares by shareholders and promoters.
The IPO consists of a fresh issue of Rs 627 crore and an offer for sale of up to 2.82 million shares by its shareholders and promoters
At close, the stock settled at Rs 872.70 on the BSE, down 8.04% from issue price of Rs 949, while its mcap stood at Rs 5.52 trillion
Delhivery has set the price band in its IPO at Rs 462-487 a share, valuing the company at Rs 35,283 crore at the upper end. This is down about 19% from the current price in the unlisted market.
Considering its size, and dominant position in the market with 66 percent market share in new business premium, its growth rate may not match up to some of the nimble footed private insurers
Motherson Sumi has launched a qualified institutional placement (QIP) through which it plans to raise Rs 1,500-2,000 crore.
The Rs 411.5-crore initial public offer of Advanced Enzyme Technologies was oversubscribed 4.28 times on the second day of the offer today.
International financial institution IFC has issued a USD 30-million, 15-year rupee-denominated "masala" bond, proceeds of which it will use towards development of private sector enterprise in India.